Novel Vancomycin-Peptide Conjugate as Potent Antibacterial Agent against Vancomycin-Resistant Staphylococcus aureus

Simple item page
dc.contributor.authorJelínková, Pavlínacs
dc.contributor.authorŠplíchal, Zbyněkcs
dc.contributor.authorJimenez Jimenez, Ana Mariacs
dc.contributor.authorHaddad, Yazan Abdulmajeed Eyadhcs
dc.contributor.authorMazumdar, Anindacs
dc.contributor.authorSur, Vishma Pratapcs
dc.contributor.authorMilosavljević, Vedrancs
dc.contributor.authorKopel, Pavelcs
dc.contributor.authorMichálková, Hanacs
dc.contributor.authorGuráň, Romancs
dc.contributor.authorZítka, Ondřejcs
dc.contributor.authorRichtera, Lukášcs
dc.contributor.authorHegerová, Dagmarcs
dc.contributor.authorHeger, Zbyněkcs
dc.contributor.authorMoulick, Amitavacs
dc.contributor.authorAdam, Vojtěchcs
dc.coverage.issue1cs
dc.coverage.volume11cs
dc.date.issued2018-11-01cs
dc.description.abstractBackground: Increase in vancomycin (Van)-resistant bacterial strains including vancomycin-resistant Staphylococcus aureus (VRSA) and lack of new effective antibiotics have become a formidable health problem. Materials and methods: We designed a new conjugate composed of Van and a peptide Hecate (Hec; Van/Hec), and its potential antimicrobial activity was evaluated. Results: Results from disk diffusion test, time-kill assay, determination of minimum inhibitory concentration (MIC), microscopy, and comet assay showed strong antimicrobial effects of Van/Hec against wild-type, methicillin-resistant Staphylococcus aureus (MRSA) and VRSA. Microscopy revealed that the exposure to Van/Hec results in disruption of bacterial cell integrity in all tested strains, which was not observed in case of Van or Hec alone. Conclusion: Overall, we showed that the preparation of conjugates from antibiotics and biologically active peptides could help us to overcome the limitation of the use of antibiotic in the treatment of infections caused by multidrug-resistant bacteria.en
dc.formattextcs
dc.format.extent1807-1817cs
dc.format.mimetypeapplication/pdfcs
dc.identifier.citationInfection and Drug Resistance. 2018, vol. 11, issue 1, p. 1807-1817.en
dc.identifier.doi10.2147/IDR.S160975cs
dc.identifier.issn1178-6973cs
dc.identifier.orcid0000-0003-4900-0020cs
dc.identifier.orcid0000-0003-1736-492Xcs
dc.identifier.orcid0000-0002-7844-4336cs
dc.identifier.orcid0000-0002-4985-7115cs
dc.identifier.orcid0000-0002-1175-7194cs
dc.identifier.orcid0000-0003-4122-0694cs
dc.identifier.orcid0000-0003-4216-9544cs
dc.identifier.orcid0000-0002-2912-714Xcs
dc.identifier.orcid0000-0001-7607-5058cs
dc.identifier.orcid0000-0002-8288-3999cs
dc.identifier.orcid0000-0003-0826-234Xcs
dc.identifier.orcid0000-0002-3915-7270cs
dc.identifier.orcid0000-0001-5769-6748cs
dc.identifier.orcid0000-0002-8527-286Xcs
dc.identifier.other151171cs
dc.identifier.researcheridH-2894-2018cs
dc.identifier.researcheridJ-2985-2015cs
dc.identifier.researcheridP-3551-2018cs
dc.identifier.researcheridE-5711-2012cs
dc.identifier.researcheridC-2610-2016cs
dc.identifier.researcheridE11072012cs
dc.identifier.researcheridN-9991-2014cs
dc.identifier.researcheridJ-7030-2012cs
dc.identifier.researcheridD-1973-2013cs
dc.identifier.researcheridI-9677-2016cs
dc.identifier.researcheridD-7686-2012cs
dc.identifier.scopus36070488100cs
dc.identifier.scopus56115133500cs
dc.identifier.scopus6603604023cs
dc.identifier.scopus14012648400cs
dc.identifier.scopus12040049600cs
dc.identifier.scopus55783172600cs
dc.identifier.urihttp://hdl.handle.net/11012/137077
dc.language.isoencs
dc.publisherDove Presscs
dc.relation.ispartofInfection and Drug Resistancecs
dc.relation.urihttps://www.dovepress.com/novel-vancomycinndashpeptide-conjugate-as-potent-antibacterial-agent-a-peer-reviewed-article-IDRcs
dc.rightsCreative Commons Attribution-NonCommercial 3.0 Unportedcs
dc.rights.accessopenAccesscs
dc.rights.sherpahttp://www.sherpa.ac.uk/romeo/issn/1178-6973/cs
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/cs
dc.subjectVancomycinen
dc.subjectantibacterialen
dc.subjectStaphylococcus aureusen
dc.subjectantibiotic resistanceen
dc.subjectpeptideen
dc.titleNovel Vancomycin-Peptide Conjugate as Potent Antibacterial Agent against Vancomycin-Resistant Staphylococcus aureusen
dc.type.driverarticleen
dc.type.statusPeer-revieweden
dc.type.versionpublishedVersionen
sync.item.dbidVAV-151171en
sync.item.dbtypeVAVen
sync.item.insts2025.02.03 15:49:45en
sync.item.modts2025.01.17 15:16:29en
thesis.grantorVysoké učení technické v Brně. Středoevropský technologický institut VUT. Chytré nanonástrojecs
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Novel vancomycinpeptide conjugate as potent antibacterial agent.pdf
Size:
3.93 MB
Format:
Adobe Portable Document Format
Description:
Novel vancomycinpeptide conjugate as potent antibacterial agent.pdf
Download
Collections
Chytré nanonástroje